Impact of progressive chronic kidney disease stage on postoperative outcomes in metabolic surgery-a propensity-matched analysis using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement database.
Florina CorpodeanMichael KachmarKyle B LaPennaDenise DanosMichael CookPhilip R SchauerVance L AlbaughPublished in: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery (2024)
Although it is generally accepted that worsening CKD correlates with greater surgical risk, this analysis identified CKD stage III as a major inflection point for risk of LOS >5 days, serious complications, and MACE. These findings are useful for counseling and procedure selection and suggest a need for heightened attention to CKD stage III patients undergoing MS.
Keyphrases
- chronic kidney disease
- patients undergoing
- quality improvement
- end stage renal disease
- bariatric surgery
- minimally invasive
- multiple sclerosis
- patient safety
- mass spectrometry
- ms ms
- weight loss
- coronary artery bypass
- working memory
- obese patients
- risk factors
- smoking cessation
- hepatitis c virus
- coronary artery disease
- drug induced